Hester Biosciences executed amendments to its subsidiary's $12M Gates Foundation loan, reducing outstanding to $5M.
The amendments include a full waiver of accrued interest and removal of future interest on the loan amount.
The company's corporate guarantee for the subsidiary's loan continues, with exposure limited to existing obligations.
The changes aim to improve the subsidiary's liquidity and debt servicing position.